Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin

Item

http://www.wikidata.org/entity/Q36617626

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@ast

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@en

type

Item

label

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@ast

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@en

prefLabel

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@ast

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@en

P1476

Loss of DNA mismatch repair fa ...... r plasmid damaged by cisplatin

@en

P2093

Aebi S

http://www.w3.org/2001/XMLSchema#string

Bubley GJ

http://www.w3.org/2001/XMLSchema#string

Cenni B

http://www.w3.org/2001/XMLSchema#string

Christen RD

http://www.w3.org/2001/XMLSchema#string

Fink D

http://www.w3.org/2001/XMLSchema#string

Howell SB

http://www.w3.org/2001/XMLSchema#string

Kim HK

http://www.w3.org/2001/XMLSchema#string

Teicher BA

http://www.w3.org/2001/XMLSchema#string

P2860

Mismatch repair: mechanisms and relationship to cancer susceptibility

In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems.

Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage.

Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.

P2888

sj.bjc.6690412

P304

699-704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6690412

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12937624

http://www.w3.org/2001/XMLSchema#string

P6179

1051466351

http://www.w3.org/2001/XMLSchema#string

P698

10360646

http://www.w3.org/2001/XMLSchema#string

P932

2362265

http://www.w3.org/2001/XMLSchema#string